Live News Categoriesmarket

IMNM.O (IMNM.O) News

Track canonical SquawkNews coverage tagged to IMNM.O, IMNM.O. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol IMNM.O Asset market Sector Markets 90 days 1 Updated Sep 30, 2026, 11:46 AM UTC Open live news feed

M Immunome gets FDA IND clearance for IM-1340 solid-tumor ADC Immunome says the FDA cleared its IND for IM-1340, a first-in-class antibody-drug conjugate for advanced solid tumors. A Phase 1 trial is slated to start in Q4 2026 to assess safety, pharmacokinetics and early anti-tumor EARNINGS | Sep 30, 2026, 11:46 AM UTC